Summary
disorders we need new techniques that do not depend on metabolic clues or on functional properties of the abnormal proteins. In meet the the pathology particular, these methods must also be able to detect abnormalities the ever expanding number of known genetic diseases in man, new in the very large number of proteins that are still unknown to us. eficient investigative techniques have to be designed. A procedure is presented for detection of protein defects in genetic diseases on the basis of structural rather than functional alterations. The
DOUBLE LABELING TECHNIQUES
technique is based on double labeling of normal and diseased
The basic principle of these techniques relies on recent advances fibroblast proteins followed by extensive fractionation and analy-in liquid scintillation counting which allow us to discriminate sis. The rationale, advantages, and limitations of the procedure between a mixture of two different radioisotopes contained in a are discussed and the technical aspects of its use explained.
single vial, provided these isotopes differ sufficiently in a nuclear property such as the energy of the particles emitted (21) . For Speculation instance, if one labels "diseased" fibroblasts in one culture dish with 3H-leucine and control fibroblasts in another dish with 14C-Application of double labeling to the systematic analysis of leucine one can combine the two strains after harvesting and cellular proteins in inherited disorders is a valuable new tool in process them identically (see Fig. 1 ). This processing involves biochemical genetics.
extensive fractionation and it would be almost impossible to treat the two strains identically otherwise. If after extensive fractionation we determine the ratio of counts due to I4C-leucine and "-Biochemical genetics is concerned with the elucidation of the leucine in each fraction we would expect ideally approximately basic genetic defect in inherited diseases. Since determination of the same ratio in every fraction. Any abnormal ratio, i.e., a ratio the precise nature of the genic defect at the DNA level is generally deviating significantly from the expected would suggest a molecnot yet feasible, efforts are directed towards identification of the ular abnormality. molecular abnormality at the level of the protein that represents
In the recent past double labeling has been applied successfully the gene product. Characterization of this protein defect provides to the investigation of the molecular athology of inherited dis-P the basis for prenatal diagnosis and carrier detection of the dis-eases. ~~~~i~~ et (26) used 3~: ' c-fUCOSe dual labeling to order and represents an essential step for a meaningful ~athoge-demonstrate anomalies in the myelin-associated 1 co roteins in !?' netic understanding of the disease process and for rational therapy. "quaking" mice and phillips et (30) used 1251: 3 ~-l~~~ dase-labeled platelet membranes to demonstrate glycoprotein ab-
NEED FOR NEW INVESTIGATIVE TECHNIQUES IN
normalities in Glanzmann's thrombasthenia. However, in both of BIOCHEMICAL GENETICS these cases, previous biochemical investigations of these disorders had suggested that the abnormalities resided in the fractions As of 1975,2336 single gene disorders were known or suspected studied. In other cases the application of dual labeling techniques in man, but the basic defect was known in only 176 (27) . Of those has not been so successful. Both Baig et al. (2) and Changus et al. 176 the great majority represents defects in enzymes or otherwise (8) applied double labeling to the study of the plasma membrane functional proteins. In many of those diseases the clue to the of cultured skin fibroblasts from patients with cystic fibrosis but nature of the functional defect was provided by the highly differ-no consistent abnormalities were detected. The point to be made entiated nature of the afflicted tissue or organ (e.g., in hemolytic here is that there is no absolute reason to believe that the basic anemias) or by the delineation and stmctural characterization of defect in cystic fibrosis is in the plasma membrane more than in the compound or compounds whose metabolism is disturbed (e.g., any other subcellular fraction and a search for molecular abnoraminoacidopathies, glycogen storage diseases). Nevertheless, a malities in this situation should include in depth analysis of all host of single gene disorders remains in which this approach is subcellular fractions. This approach was partially taken by not possible because a clue to the nature of the basic defect is not Fletcher and Lin (12). We believe that, provided that the mutant apparent. Most of the dysmorphogenetic syndromes and also protein can be differentiated from the wild type either by being important diseases such as cystic fibrosis, Duchenne muscular present in reduced amounts or by detectable structural alterations, dystrophy, and Huntington's chorea fall into this category. In this and provided that suff~cient fractionation is performed, double context, it is important to emphasize that somatic cells contain a labeling should always reveal the molecular defect in a genetic very great number of proteins, perhaps of the order of 20,000 (35) . disease. Of course, these are ideal circumstances that are seldom but that we only know a relatively small number of them-only realized in practice. Nevertheless, we propose that application of approximately 1300 enzymes were known in 1968(3). For the double labeling to the systematic analysis of cellular proteins in efficient investigation of the molecular pathology of inherited genetic diseases is a valuable new tool that deserves further 887 DOUBLE LABELING TECHNIQUE IN MOLECULAR DEFECTS. I.
POLYACRYLAMIDE GEL ELECTROPHORESIS IN PRESENCE OF SODIUM DODECYL SULFATE (SDS-PAGE)
Aliquots of subcellular fractions were suspended in 500 p1 1% SDS (Sigma) in 625 mM Tris-HC1 (pH 6.8), and disrupted for 2 min at 100°. Samples were then made 1% in P-mercaptoethanol and heated again at 100" for 1 min followed by the addition of 1 drop of glycerol and 10 p1 of a 0.01% aqueous solution of bromophenol blue. SDS electrophoresis (SDS-PAGE) was performed using the discontinuous buffer system of Maize1 (25) . Stacking gels contained 0.1% SDS, 3.0% (w/v) acrylamide (BIORAD), 38%.(w/v) N,N1-methylene-bis-acrylamide (Bis, BIORAD), and were polymerized by the addition of 0.125% (v/v) N,N,N',N'-tetramethylenediamine (TEMED, Eastman) and 0.10% (w/v) ammonium persulfate. Separating gels contained 6 M urea, 13% or 10% acrylamide, and 0.26% or 0.20% Bis, respectively, and were polymerized by the addition of 0.06% TEMED and 0.04% ammonium persulfate. Separating gels were cast to a height of 20 cm in 0.6 x 25-cm tubes and stacking gels measured 2 cm. Electrode buffer contained 50 mM Tris, 0.38 M glycine, and 0.1% SDS, pH 8.3. A constant voltage of 60 V was applied until the sample had entered the stacking gel followed by 120 V for approximately 20 hr. Bovine serum albumin, ovalbumin, alcohol dehydrogenase, a-chymotrypsinogen, myoglobin, lysozyme, and ribonuclease (all obtained from Sigma) were used as molecular weight markers.
GEL ISOELECTRIC FOCUSING (IEF)
Gels containing 1% ampholines (LKB), pH 3.5-10, 5.0% acrylamide, and 0.17% Bis were cast in 0.6 x 16-cm tubes. The samples were polymerized into the gel. Focusing was carried out in an apparatus of our own design which allows use of small (50-ml) electrolyte volumes and provides cooling in direct contact with the gel tubes. The upper (anode) compartment contained 5% (v/v) orthophosphoric acid and the lower one 5% (v/v) ethylenediamine. The temperature was maintained at 4" and the power, provided by an Ortec 4100 pulsed constant power supply, was regulated as follows: 50 V for 0.5 hr, 100 V for 1 hr, and 150 V for 16 hr, all at a pulse rate of 50 pps and at 0.5 microfarads. At the end of the run the power was raised to 300 V and 100 pps for 2 min and 400 V and 200 pps for 2 min. This scheme was modified from that of Klose (23) . The pH gradient was determined by cutting the gel into 2-mm minced fractions with a Gilson Aliquogel fractionator and measuring the pH at 5' in 0.5-ml water extracts with a Radiometer PHM62 standard pH meter equipped with a ---Radiometer pH microelectrode.
ASSAY OF RADIOACTIVITY IN GELS
Gels were sliced in 2-mm fractions, minced, and extruded directly into scintillation vials by a Gilson Aliquogel fractionator. After drying overnight in an oven at SO0 the vials were prepared for counting by sequential additian of 100 pl HzO, 600 p1 NCS tissue solubilizer (Amersham-Searle Co.) and 12 ml of a scintillation cocktail containing 0.4% Omnifluor (New England Nuclear) in toluene. After capping vials were vigorously mixed and stored overnight in the dark before counting. Samples were counted to 5% accuracy in Beckmann scintillation systems, model LS350, LS250, or LS150, all equipped and operated with automatic quench compensation, and contained at least 12,000 cpm of each radioisotope. Counting efficiencies with narrow 3H and I4C windows were approximately 38% and 71%. respectively. Quench curves were prepared as described by Boeckx et al. (5). Vials with less than twice background counts were ignored in the analysis.
ANALYSIS AND PLOTTING OF DATA
Liquid scintillation data were punched on paper tape and analyzed by a computer program, SCINT I1 (36) operative in a CDC (Control Data Corporation) 1700 computer system. This program, an expanded version of SCINT (5), performs individual quench correction and compensation for spillover of 14C counts into the 3H channel. The program computes disintegrations per min and picomoles of isotope incorporated into each fraction and the ratio of 14C?H incorporation, normalizes these data, and plots them against gel fractions. The program also calculates and prints several useful statistics such as the variance and standard deviation of the normalized 14C:3H ratio.
RESULTS AND DISCUSSION

VARIABILITY IN TECHNIQUE
In order to determine the resolution of the technique as well as to have an idea of the factors determining variability in the system, control experiments involving comparison of identical or radically different protein populations were performed. In the first experiment, shown in Figure 2 , the same culture flask was labeled with both I4C-and 3H-leucine. The profiles should be identical and differences between them represent the lower limit of resolution by the system. It can be seen from the small fluctuation of the normalized 14C:3H ratio that differences were indeed very small. In marked contrast is the plot shown in Figure 3 , which displays a comparison of the supernatant proteins of a human fibroblast strain (KBF) and a Chinese hamster fibroblast line (CHW-1102). Here the distributions are markedly different and the '4C:3H ratios show wide fluctuations. A useful summarizing index of the differences between protein distributions seems to be the VNR, i.e., the variance of the normalized '4C:3H ratio; its numeric value is 0.00 18 for Fieure 2 and 0.0727 for Fieure 3. To ascertain whether the " VNR 7s truly a useful index, two experiments, each comparing 14C-and 3H-labeled supernatant proteins from replicate cultures of the same strain (not shown) and supernatant proteins from different human fibroblast strains obtained from normal individuals, were performed (Fig. 4) . The VNRs for all these distributions are shown in Table 1 . Examination of these numbers reveals a correlation between the expected degree of difference of the profiles and the VNR. Accordingly, the VNR of the comparison shown in Figure 2 represents random error in the distribution and counting of the two isotopes, i.e., the variance inherent in the technical procedures. The VNRs of the comparisons of replicate dishes of the same fibroblast strains are on average slightly larger than the one of Figure 2 , indicating the very small added variability of culture conditions. Even larger is the VNR of the comparison of different normal fibroblast strains (Fig. 4) , probably reflecting differences in the genotype of the strains, i.e., biochemical individuality, but also epigenetic phenomena. human-hamster comparison reflects differences between different species. In this context it would be interesting to examine whether the VNR of comparisons between species correlates with evolutionary divergence and whether it could then be used as a measure of genetic distance.
DEFINITION OF ABNORMAL RATIO
In single gene disorders we expect biochemical abnormalities to be confined to very few proteins, most often just one. This abnormality will hopefully be expressed as a "significant" deviation of the 14C?H ratio from average in one or a few vials. We arbitrarily consider "significant" a deviation larger than 2 SD. To facilitate visual ascertainment of deviant ratios, lines indicate the 2 SD value in the ratios plot.
In order to have an idea of how often marked ratio abnormalities can be found in the absence of disease as well as to have an idea of factors contributing to their appearance, two leucine double labeling experiments comparing "normal" strains were performed. Figures 4 and 5 are good examples of the several plots obtained. Although the variability is low, some deviant ratios are immediately apparent on observation of these plots.
In Figure 5 an area of excess I4C-leucine counts can be identified just ahead of the tracking dye (T.D.) area. This "defect" was seen (32) , which is generally considered to be due to lipid components migrating to that area of the gel, perhaps together with SDS micelles. The relative excess of 4C radioactivity observed is caused by differential metabolism of radioactive carbon and hydrogen atoms (14C-leucine is uniformly labeled whereas 3H-leucine is labeled only in positions 4 and 5) in the conversion of leucine to acetyl-CoA and acetoacetate, which are lipid precursors (24). Since these "lipid abnormalities" inflate the VNRs, the lines indicating 2 SD values in the plot of normalized ratios become rather useless. In order to preserve this most useful visual guideline, we have consistently obtained new ratio plots after removing the computer cards with the anomalous "lipid" ratios. In consequence, the figures presented in this and the following articles will show the "lipid defects" (whenever present) only in the "% DPM" plot. Corresponding deviations will not be seen in the plots of the normalized 14C:3H ratios. The fairly common observation of deviant ratios in comparisons of strains derived from apparently normal individuals is disturbing. Obviously these deviant ratios did not originate from "true molecular defects" but rather represent, as mentioned above, genotypic and epigenetic differences between normal strains. If double labeling is to be useful for the study of diseases, it is evident that we need to define criteria by which to distinguish true "abnormal" ratios from those deviations arising from nonpathologic differences between strains. We should be aware that as soon as these criteria are established and followed, errors of classification will be made, since the criteria will not be perfect. In analogy to statistical significance testing we can classify these errors in two main categories (see Table 2 ).
Type I Error. This type of error occurs if we consider a ratio abnormal when in fact it is caused by nonpathologic differences. Possible causes for this kind of error are many and only a few are listed in Table 2 . Nevertheless, we can minimize the probability of incurring such errors by carefully controlling the tissue culture conditions and by incorporating into our criteria for abnormality or ratios the necessity for highest reproducibility. Accordingly, to be considered abnormal a deviant ratio should repeat itself with Rigorous control o f culture conditions Repeated with different "diseased" a n d control strains Reverse labels T y p e I1 error (missing a defect when i n fact it is present) Causes: Weak signal t o noise ratio "Cover-up" effect Solution:
Increase analytic resolution Change labels different strains of "diseased" and control fibroblasts and also should be independent of which strain receives the 3H or 14C label.
We are aware that occasionally genetic heterogeneity (4, 7) may be responsible for the nonreproducibility of deviant ratios and this possibility should be taken into consideration when one of several mutant strains behaves anomalously. Type II Error. This type of error consists in missing a molecular abnormality when it is in fact present. We believe this type of error to be more serious and more difficult to avoid than the type I error. It has two main causes which will be discussed below--Weak signal ro noise rario: Sometimes the protein which is abnormal may be present in very small amounts or incorporates leucine poorly. A solution to this problem, whenever possible, is to use other labels. For instance, we know that glycoproteins constitute only a fraction of all leucine-labeled proteins but they can be examined selectively by glucosamine or fucose labeling. Also, we have to consider the possibility that the mutant protein, although abnormal in structure, may be present in normal amounts and not differ from the wild type in molecular weight or charge and hence not be detected by SDS-PAGE or IEF, respectively. In this case the molecular defect would not be detected by the double labeling procedure. However, we believe that the probability of this occurrence is small. Evidence has been mounting in recent years in favor of the concept that structurally abnormal proteins may be selectively degraded at a faster rate than normal ones in both bacterial and mammalian systems (14, 15, 31) . Accordingly, Capechi et al. (6) found decreased levels of enzvme rote in in all of four cross-reactive material ~ositive , n missense mutants of hypoxanthine-guanine-phosphoribosyltransferase in mouse L cells. It is then evident that the presence of mutant proteins in normal amounts should be an uncommon phenomenon in genetic diseases.
"Cover-up" effect: The extent of analytical fractionation now possible is limited if compared to the total number of proteins present in the cell. The ideal situation of having one protein only per fraction is generally not feasible. Abnormal ratios generated by decreased or absent label incorporation in a mutant protein PAGE in glass tubes. We are currently investigating the poisibility of using the recently developed double label autoradiography method (16) in conjunction with the newer high resolution twodimensional electrophoresis of proteins (1, 28).
C R I T E R I A F O R A B N O R M A L I T Y OF R A T I O S
With the above considerations in mind we can now define criteria for considering a given ratio abnormal. As mentioned previously these criteria are arbitrary and occasionally one of them may have to be waived. They are: 1) the ratio should deviate more than 2 SD from the mean; 2) a deviant ratio should correspond to a protein peak in the profile; 3) the deviant ratio should be reproducible with different disease and control fibroblast strains; 4) the reversal of the labels should result in a ratio deviation in the opposite direction.
To examine better these criteria as well as to test clinically the power of double labeling in detecting molecular defects in genetic diseases we applied our technique to a model disease, Pompe's disease (glycogenosis 11) a lysosomal disease associated with deficiency of acid a-1,4-glucosidase (acid maltase) activity (1 8, 19) . Results of these experiments will be presented in the next article in this series (29) .
We propose that application of double labeling in conjunction with extensive protein fractionation to the systematic analysis of genetic diseases is a valuable new tool in biochemical genetics. The principles and limitations of the technique were discussed and the technical aspects of its use explained. The technique does not depend on metabolic clues or on functional properties of the defective protein, and hence can be applied to genetic disorders of obscure physiopathology. Using the abnormal ratio as a marker, biochemical characterization of the protein involved is possible in terms of structural properties such as molecular weight and isoelectric point permitting in a few cases identification of the protein by reference to standard tables (10, 20, 33).
We hope that application of this technique to important diseases of obscure pathophysiology such as cystic fibrosis, Duchenne muscular dystrophy, and Huntington's chorea will lead to characterization of molecular defects in tissue culture cells and that in turn these findings will lead to better pathogenetic understanding of these disorders and hopefully prenatal diagnosis of these con- 3). This is another aspect of the "cover-up" effect and points to Amer. J. Pathol., 80: 317 (1975 
